| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 3.41e-06 | 5 | 141 | 3 | GO:0005025 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK3 DENND5B RAPGEF6 SWAP70 RGS5 TBC1D2B RGS1 RGS16 NPRL2 PLCB1 PLCG1 DENND5A TBC1D21 AGAP3 | 1.47e-05 | 507 | 141 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK3 DENND5B RAPGEF6 SWAP70 RGS5 TBC1D2B RGS1 RGS16 NPRL2 PLCB1 PLCG1 DENND5A TBC1D21 AGAP3 | 1.47e-05 | 507 | 141 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | BMP receptor activity | 1.88e-05 | 8 | 141 | 3 | GO:0098821 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 7.24e-05 | 12 | 141 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 9.36e-05 | 13 | 141 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPC7 TRPC3 TRPC6 GRIN2C NMUR2 SHROOM2 CLCC1 KCNJ1 SCN1A GLRA1 PKD1 SCN9A | 1.03e-04 | 459 | 141 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.19e-04 | 14 | 141 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity | 1.48e-04 | 3 | 141 | 2 | GO:0048101 | |
| GeneOntologyMolecularFunction | calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity | 1.48e-04 | 3 | 141 | 2 | GO:0004117 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.67e-04 | 279 | 141 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.60e-04 | 18 | 141 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.94e-04 | 4 | 141 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 2.94e-04 | 4 | 141 | 2 | GO:0047655 | |
| GeneOntologyMolecularFunction | channel activity | TRPC7 TRPC3 TRPC6 GRIN2C NMUR2 SHROOM2 CLCC1 KCNJ1 SCN1A GLRA1 PKD1 SCN9A | 3.55e-04 | 525 | 141 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 3.60e-04 | 20 | 141 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPC7 TRPC3 TRPC6 GRIN2C NMUR2 SHROOM2 CLCC1 KCNJ1 SCN1A GLRA1 PKD1 SCN9A | 3.61e-04 | 526 | 141 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 4.24e-04 | 386 | 141 | 10 | GO:0042578 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 6.26e-04 | 97 | 141 | 5 | GO:0008081 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 7.29e-04 | 6 | 141 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.53e-04 | 343 | 141 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 7.69e-04 | 153 | 141 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.96e-04 | 26 | 141 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B DDX19A ATP8B4 RGS5 CHD1 CHD2 RFC1 RGS1 ABCA9 RGS16 SHOC1 ENPP5 DNAH5 DNAH8 AGAP3 | 8.81e-04 | 839 | 141 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B DDX19A ATP8B4 RGS5 CHD1 CHD2 RFC1 RGS1 ABCA9 RGS16 SHOC1 ENPP5 DNAH5 DNAH8 AGAP3 | 8.92e-04 | 840 | 141 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B DDX19A ATP8B4 RGS5 CHD1 CHD2 RFC1 RGS1 ABCA9 RGS16 SHOC1 ENPP5 DNAH5 DNAH8 AGAP3 | 8.92e-04 | 840 | 141 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.92e-04 | 28 | 141 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.18e-03 | 441 | 141 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B DDX19A ATP8B4 RGS5 CHD1 CHD2 RFC1 RGS1 ABCA9 RGS16 SHOC1 DNAH5 DNAH8 AGAP3 | 1.19e-03 | 775 | 141 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.26e-03 | 230 | 141 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.73e-03 | 9 | 141 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 2.07e-03 | 36 | 141 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.23e-03 | 129 | 141 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.25e-03 | 37 | 141 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK3 DENND5B VIL1 RAPGEF6 SWAP70 RGS5 TBC1D2B PPP2R3B RFC1 RGS1 RGS16 CCNC NPRL2 THADA PLCB1 PLCG1 DENND5A TBC1D21 NOS2 AGAP3 | 2.31e-03 | 1418 | 141 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.51e-03 | 193 | 141 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.78e-03 | 197 | 141 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.90e-03 | 211 | 141 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DDX19A ATP8B4 CHD1 CHD2 RFC1 ABCA9 DNAH1 SHOC1 DNAH5 DNAH8 | 4.25e-03 | 614 | 141 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 4.26e-03 | 14 | 141 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.26e-03 | 14 | 141 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 4.26e-03 | 14 | 141 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.39e-03 | 151 | 141 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.42e-03 | 288 | 141 | 7 | GO:0016757 | |
| HumanPheno | Focal non-motor seizure | 4.29e-06 | 40 | 57 | 6 | HP:0032679 | |
| HumanPheno | EEG with focal epileptiform discharges | 5.00e-06 | 118 | 57 | 9 | HP:0011185 | |
| HumanPheno | Multifocal epileptiform discharges | 7.03e-06 | 66 | 57 | 7 | HP:0010841 | |
| Domain | TRP_2 | 7.43e-06 | 6 | 136 | 3 | PF08344 | |
| Domain | TRP_dom | 7.43e-06 | 6 | 136 | 3 | IPR013555 | |
| Domain | GS_dom | 1.29e-05 | 7 | 136 | 3 | IPR003605 | |
| Domain | GS | 1.29e-05 | 7 | 136 | 3 | PS51256 | |
| Domain | TGF_beta_GS | 1.29e-05 | 7 | 136 | 3 | PF08515 | |
| Domain | TRPC_channel | 1.29e-05 | 7 | 136 | 3 | IPR002153 | |
| Domain | GS | 1.29e-05 | 7 | 136 | 3 | SM00467 | |
| Domain | - | 1.46e-05 | 21 | 136 | 4 | 2.60.60.20 | |
| Domain | PLAT | 1.46e-05 | 21 | 136 | 4 | PF01477 | |
| Domain | PLAT/LH2_dom | 1.46e-05 | 21 | 136 | 4 | IPR001024 | |
| Domain | PLAT | 1.46e-05 | 21 | 136 | 4 | PS50095 | |
| Domain | TRP_channel | 5.97e-05 | 11 | 136 | 3 | IPR004729 | |
| Domain | KRAB | ZNF510 ZFP69 ZNF440 ZNF3 ZNF540 ZNF589 ZNF808 ZNF264 ZNF578 ZNF439 ZNF114 | 6.33e-05 | 358 | 136 | 11 | PS50805 |
| Domain | KRAB | ZNF510 ZFP69 ZNF440 ZNF3 ZNF540 ZNF589 ZNF808 ZNF264 ZNF578 ZNF439 ZNF114 | 6.33e-05 | 358 | 136 | 11 | PF01352 |
| Domain | TGFB_receptor | 7.92e-05 | 12 | 136 | 3 | IPR000333 | |
| Domain | KRAB | ZNF510 ZFP69 ZNF440 ZNF3 ZNF540 ZNF589 ZNF808 ZNF264 ZNF578 ZNF439 ZNF114 | 8.29e-05 | 369 | 136 | 11 | SM00349 |
| Domain | KRAB | ZNF510 ZFP69 ZNF440 ZNF3 ZNF540 ZNF589 ZNF808 ZNF264 ZNF578 ZNF439 ZNF114 | 8.50e-05 | 370 | 136 | 11 | IPR001909 |
| Domain | RGS | 1.18e-04 | 35 | 136 | 4 | PF00615 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.30e-04 | 14 | 136 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.30e-04 | 14 | 136 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.30e-04 | 14 | 136 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.30e-04 | 14 | 136 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.30e-04 | 14 | 136 | 3 | IPR011704 | |
| Domain | MT | 1.30e-04 | 14 | 136 | 3 | PF12777 | |
| Domain | AAA_8 | 1.30e-04 | 14 | 136 | 3 | PF12780 | |
| Domain | AAA_5 | 1.30e-04 | 14 | 136 | 3 | PF07728 | |
| Domain | RGS | 1.32e-04 | 36 | 136 | 4 | PS50132 | |
| Domain | DUF4208 | 1.57e-04 | 3 | 136 | 2 | PF13907 | |
| Domain | DUF4208 | 1.57e-04 | 3 | 136 | 2 | IPR025260 | |
| Domain | PDEase_N | 1.57e-04 | 3 | 136 | 2 | IPR013706 | |
| Domain | PDEase_I_N | 1.57e-04 | 3 | 136 | 2 | PF08499 | |
| Domain | DUF4208 | 1.57e-04 | 3 | 136 | 2 | SM01176 | |
| Domain | DHC_fam | 1.61e-04 | 15 | 136 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.61e-04 | 15 | 136 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.61e-04 | 15 | 136 | 3 | IPR004273 | |
| Domain | RGS | 1.82e-04 | 39 | 136 | 4 | IPR016137 | |
| Domain | FerI | 5.19e-04 | 5 | 136 | 2 | SM01202 | |
| Domain | FerB | 5.19e-04 | 5 | 136 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 5.19e-04 | 5 | 136 | 2 | IPR012561 | |
| Domain | Ferlin_C | 5.19e-04 | 5 | 136 | 2 | PF16165 | |
| Domain | Ferlin_C | 5.19e-04 | 5 | 136 | 2 | IPR032362 | |
| Domain | FerIin_dom | 5.19e-04 | 5 | 136 | 2 | IPR012968 | |
| Domain | FerI | 5.19e-04 | 5 | 136 | 2 | PF08151 | |
| Domain | FerB | 5.19e-04 | 5 | 136 | 2 | PF08150 | |
| Domain | - | 5.26e-04 | 22 | 136 | 3 | 1.10.196.10 | |
| Domain | RGS_subdom1 | 5.26e-04 | 22 | 136 | 3 | IPR024066 | |
| Domain | Na_trans_cytopl | 7.75e-04 | 6 | 136 | 2 | PF11933 | |
| Domain | EPTP | 7.75e-04 | 6 | 136 | 2 | PF03736 | |
| Domain | EPTP | 7.75e-04 | 6 | 136 | 2 | IPR005492 | |
| Domain | CP2 | 7.75e-04 | 6 | 136 | 2 | PF04516 | |
| Domain | CP2 | 7.75e-04 | 6 | 136 | 2 | IPR007604 | |
| Domain | Na_trans_cytopl | 7.75e-04 | 6 | 136 | 2 | IPR024583 | |
| Domain | EAR | 1.08e-03 | 7 | 136 | 2 | IPR009039 | |
| Domain | EAR | 1.08e-03 | 7 | 136 | 2 | PS50912 | |
| Domain | EF-hand-dom_pair | 1.22e-03 | 287 | 136 | 8 | IPR011992 | |
| Domain | DHC_N1 | 1.43e-03 | 8 | 136 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.43e-03 | 8 | 136 | 2 | IPR013594 | |
| Domain | Ion_trans_dom | 1.48e-03 | 114 | 136 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.48e-03 | 114 | 136 | 5 | PF00520 | |
| Domain | RGS | 2.08e-03 | 35 | 136 | 3 | SM00315 | |
| Domain | Na_channel_asu | 2.28e-03 | 10 | 136 | 2 | IPR001696 | |
| Domain | ALDOKETO_REDUCTASE_1 | 2.28e-03 | 10 | 136 | 2 | PS00798 | |
| Domain | Na_trans_assoc | 2.28e-03 | 10 | 136 | 2 | IPR010526 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.28e-03 | 10 | 136 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.28e-03 | 10 | 136 | 2 | PS00063 | |
| Domain | Phosphodiest/P_Trfase | 2.28e-03 | 10 | 136 | 2 | IPR002591 | |
| Domain | Activin_recp | 2.28e-03 | 10 | 136 | 2 | PF01064 | |
| Domain | Na_trans_assoc | 2.28e-03 | 10 | 136 | 2 | PF06512 | |
| Domain | Activin_recp | 2.28e-03 | 10 | 136 | 2 | IPR000472 | |
| Domain | Aldo/ket_reductase_CS | 2.28e-03 | 10 | 136 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.28e-03 | 10 | 136 | 2 | IPR020471 | |
| Domain | Phosphodiest | 2.28e-03 | 10 | 136 | 2 | PF01663 | |
| Domain | uDENN | 4.52e-03 | 14 | 136 | 2 | SM00800 | |
| Domain | - | 4.58e-03 | 148 | 136 | 5 | 2.60.40.150 | |
| Domain | LDLRA_1 | 5.14e-03 | 48 | 136 | 3 | PS01209 | |
| Domain | EF-hand_like | 5.19e-03 | 15 | 136 | 2 | PF09279 | |
| Domain | uDENN | 5.19e-03 | 15 | 136 | 2 | PF03456 | |
| Domain | PI-PLC-Y | 5.19e-03 | 15 | 136 | 2 | PF00387 | |
| Domain | PLCYc | 5.19e-03 | 15 | 136 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 5.19e-03 | 15 | 136 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 5.19e-03 | 15 | 136 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 5.19e-03 | 15 | 136 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 5.19e-03 | 15 | 136 | 2 | IPR015359 | |
| Domain | LDLRA_2 | 5.45e-03 | 49 | 136 | 3 | PS50068 | |
| Domain | DENN | 5.91e-03 | 16 | 136 | 2 | SM00799 | |
| Domain | Galactosyl_T | 5.91e-03 | 16 | 136 | 2 | PF01762 | |
| Domain | DENN | 5.91e-03 | 16 | 136 | 2 | PF02141 | |
| Domain | dDENN | 5.91e-03 | 16 | 136 | 2 | PF03455 | |
| Domain | UDENN | 5.91e-03 | 16 | 136 | 2 | PS50946 | |
| Domain | DDENN | 5.91e-03 | 16 | 136 | 2 | PS50947 | |
| Domain | Glyco_trans_31 | 5.91e-03 | 16 | 136 | 2 | IPR002659 | |
| Domain | dDENN | 5.91e-03 | 16 | 136 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.91e-03 | 16 | 136 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.91e-03 | 16 | 136 | 2 | IPR005113 | |
| Domain | DENN | 5.91e-03 | 16 | 136 | 2 | PS50211 | |
| Domain | - | 5.91e-03 | 16 | 136 | 2 | 3.20.20.100 | |
| Domain | DENN_dom | 5.91e-03 | 16 | 136 | 2 | IPR001194 | |
| Domain | Gal_mutarotase_SF_dom | 6.66e-03 | 17 | 136 | 2 | IPR011013 | |
| Domain | NADP_OxRdtase_dom | 6.66e-03 | 17 | 136 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 6.66e-03 | 17 | 136 | 2 | PF00248 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 8.50e-07 | 10 | 115 | 4 | M27330 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 5.47e-05 | 210 | 115 | 9 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 7.05e-05 | 217 | 115 | 9 | M18437 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 28526717 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 7750489 | ||
| Pubmed | DENND5B LYPD6B RGSL1 TRPC6 CHD2 ZNF510 GCNT4 GRHL2 ADGRL4 MTM1 PKD1 SCN9A SHOC1 PLD1 SARDH | 1.41e-07 | 686 | 141 | 15 | 29987050 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 30017393 | ||
| Pubmed | Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. | 2.60e-07 | 4 | 141 | 3 | 17023658 | |
| Pubmed | RAPGEF6 RNMT UGGT1 CHD2 HEATR1 COLGALT1 SHROOM2 LDLR PACS1 AREL1 BMPR1A TIA1 PIK3CD KCNJ1 PLCG1 PLD1 PLEC HERC4 | 4.43e-07 | 1084 | 141 | 18 | 11544199 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 21261756 | ||
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 6.48e-07 | 5 | 141 | 3 | 20351294 | |
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 18272594 | ||
| Pubmed | 1.47e-06 | 21 | 141 | 4 | 30270038 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 2.26e-06 | 7 | 141 | 3 | 15757897 | |
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 12065756 | ||
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 2.26e-06 | 7 | 141 | 3 | 15336983 | |
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 9256245 | ||
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 32350291 | ||
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 38835669 | ||
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 36257322 | ||
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 25471572 | ||
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 15199065 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 3.60e-06 | 8 | 141 | 3 | 12032305 | |
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 23250207 | ||
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 16049014 | ||
| Pubmed | Variations in DNA elucidate molecular networks that cause disease. | 5.38e-06 | 9 | 141 | 3 | 18344982 | |
| Pubmed | 5.38e-06 | 9 | 141 | 3 | 17480026 | ||
| Pubmed | 5.38e-06 | 9 | 141 | 3 | 15623527 | ||
| Pubmed | 5.38e-06 | 9 | 141 | 3 | 11290752 | ||
| Pubmed | 7.67e-06 | 10 | 141 | 3 | 15611116 | ||
| Pubmed | 7.67e-06 | 10 | 141 | 3 | 27177420 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 7.67e-06 | 10 | 141 | 3 | 18989690 | |
| Pubmed | Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). | 7.67e-06 | 10 | 141 | 3 | 11266516 | |
| Pubmed | 9.67e-06 | 33 | 141 | 4 | 19834762 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 AMD1 CHD2 VPS54 SHROOM2 GRHL2 CLCC1 ZNF440 DNAH1 PACS1 BMPR1B THADA GTF2I ZNF589 ENPP5 PLCG1 DENND5A EIF4G3 AGAP3 | 9.79e-06 | 1489 | 141 | 19 | 28611215 |
| Pubmed | BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. | 1.05e-05 | 11 | 141 | 3 | 20406889 | |
| Pubmed | Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. | 1.05e-05 | 11 | 141 | 3 | 19758997 | |
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 1.63e-05 | 2 | 141 | 2 | 34954342 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22724068 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14976057 | ||
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 1.63e-05 | 2 | 141 | 2 | 25120755 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15337738 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 21087085 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 8526877 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 9730621 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 36518763 | ||
| Pubmed | Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. | 1.63e-05 | 2 | 141 | 2 | 15744307 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12063259 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10850425 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15371096 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 28357470 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 1.63e-05 | 2 | 141 | 2 | 20190513 | |
| Pubmed | Similarity of molecular phenotype between known epilepsy gene LGI1 and disease candidate gene LGI2. | 1.63e-05 | 2 | 141 | 2 | 20863412 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15322331 | ||
| Pubmed | Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models. | 1.63e-05 | 2 | 141 | 2 | 30120731 | |
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 1.63e-05 | 2 | 141 | 2 | 33644071 | |
| Pubmed | Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. | 1.63e-05 | 2 | 141 | 2 | 16127462 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 11761087 | ||
| Pubmed | The structure and function of murine factor V and its inactivation by protein C. | 1.63e-05 | 2 | 141 | 2 | 9616155 | |
| Pubmed | Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells. | 1.63e-05 | 2 | 141 | 2 | 25652401 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 32764110 | ||
| Pubmed | Williams-Beuren syndrome hypercalcemia: is TRPC3 a novel mediator in calcium homeostasis? | 1.63e-05 | 2 | 141 | 2 | 22566418 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15766521 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14597397 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20673479 | ||
| Pubmed | Functional characterization of recombinant FV Hong Kong and FV Cambridge. | 1.63e-05 | 2 | 141 | 2 | 12091344 | |
| Pubmed | Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. | 1.63e-05 | 2 | 141 | 2 | 12091346 | |
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 1.63e-05 | 2 | 141 | 2 | 21276782 | |
| Pubmed | Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis. | 1.63e-05 | 2 | 141 | 2 | 11369604 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23529130 | ||
| Pubmed | Polymorphisms in the protein C gene as risk factor for venous thrombosis. | 1.63e-05 | 2 | 141 | 2 | 19132190 | |
| Pubmed | Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). | 1.63e-05 | 2 | 141 | 2 | 23216621 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 31911858 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 33333171 | ||
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 1.63e-05 | 2 | 141 | 2 | 12970363 | |
| Pubmed | PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. | 1.63e-05 | 2 | 141 | 2 | 24470487 | |
| Pubmed | Obligatory role for phospholipase C-gamma(1) in villin-induced epithelial cell migration. | 1.63e-05 | 2 | 141 | 2 | 17229814 | |
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 1.63e-05 | 2 | 141 | 2 | 9930701 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12142344 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14660667 | ||
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 1.63e-05 | 2 | 141 | 2 | 25297984 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15102710 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24453217 | ||
| Pubmed | Single nucleotide variants in the protein C pathway and mortality in dialysis patients. | 1.63e-05 | 2 | 141 | 2 | 24816905 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23248035 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19651781 | ||
| Pubmed | Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells. | 1.63e-05 | 2 | 141 | 2 | 27869117 | |
| Pubmed | Effect of hyperhomocysteinemia on protein C activation and activity. | 1.63e-05 | 2 | 141 | 2 | 12200374 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 35320283 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25213992 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 7578036 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17724165 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22168450 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 27861908 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 8541228 | ||
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 1.63e-05 | 2 | 141 | 2 | 29700422 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 35332432 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23800468 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15857855 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 28105583 | ||
| Pubmed | Villin enhances hepatocyte growth factor-induced actin cytoskeleton remodeling in epithelial cells. | 1.63e-05 | 2 | 141 | 2 | 12937273 | |
| Interaction | TRPC3 interactions | 3.06e-06 | 33 | 140 | 5 | int:TRPC3 | |
| Interaction | TRPC7 interactions | 6.46e-06 | 6 | 140 | 3 | int:TRPC7 | |
| Interaction | NT5M interactions | 2.67e-05 | 9 | 140 | 3 | int:NT5M | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 6.74e-06 | 7 | 106 | 3 | 345 | |
| GeneFamily | Dyneins, axonemal | 1.25e-04 | 17 | 106 | 3 | 536 | |
| GeneFamily | Regulators of G-protein signaling | 2.41e-04 | 21 | 106 | 3 | 720 | |
| GeneFamily | Ferlin family | 5.03e-04 | 6 | 106 | 2 | 828 | |
| GeneFamily | Transient receptor potential cation channels | 5.77e-04 | 28 | 106 | 3 | 249 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.19e-03 | 9 | 106 | 2 | 1203 | |
| GeneFamily | Phospholipases | 1.90e-03 | 42 | 106 | 3 | 467 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF510 ZFP69 ZNF440 ZNF3 ZNF540 ZNF589 ZNF808 ZNF264 ZNF578 ZNF439 ZNF114 | 3.25e-03 | 718 | 106 | 11 | 28 |
| GeneFamily | Aldo-keto reductases | 3.40e-03 | 15 | 106 | 2 | 399 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 5.46e-03 | 19 | 106 | 2 | 832 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP | 2.83e-06 | 162 | 141 | 8 | M8883 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-07 | 187 | 141 | 8 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-07 | 189 | 141 | 8 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.78e-07 | 191 | 141 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-06 | 181 | 141 | 7 | c7a220891567c7539ad5a9ac9db375f0de08ea00 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 116 | 141 | 6 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 1.96e-06 | 183 | 141 | 7 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 183 | 141 | 7 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 183 | 141 | 7 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.03e-06 | 184 | 141 | 7 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.03e-06 | 184 | 141 | 7 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 186 | 141 | 7 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 186 | 141 | 7 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 2.26e-06 | 187 | 141 | 7 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 188 | 141 | 7 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 188 | 141 | 7 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.43e-06 | 189 | 141 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 190 | 141 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.51e-06 | 190 | 141 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.60e-06 | 191 | 141 | 7 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-06 | 191 | 141 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.79e-06 | 193 | 141 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.79e-06 | 193 | 141 | 7 | aa10924b203c71e65fdbd2b90ba131dbd362d8b1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 193 | 141 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.79e-06 | 193 | 141 | 7 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.79e-06 | 193 | 141 | 7 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 194 | 141 | 7 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 194 | 141 | 7 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 194 | 141 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.99e-06 | 195 | 141 | 7 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-06 | 196 | 141 | 7 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.09e-06 | 196 | 141 | 7 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-06 | 198 | 141 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-06 | 198 | 141 | 7 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-06 | 199 | 141 | 7 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tmem163_Dmrtb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.79e-06 | 136 | 141 | 6 | 0376c2907b869c7d42f57af7f65ffdd6246c4d27 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.06e-06 | 152 | 141 | 6 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 155 | 141 | 6 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-05 | 156 | 141 | 6 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-05 | 156 | 141 | 6 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 157 | 141 | 6 | 2b60de520edf167f5ca790b478557a778435b3d9 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 157 | 141 | 6 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 157 | 141 | 6 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-05 | 157 | 141 | 6 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 160 | 141 | 6 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 1.45e-05 | 165 | 141 | 6 | 1ae1ad4e1fe19b6eefff0f9a03d58a384f169759 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-05 | 167 | 141 | 6 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 168 | 141 | 6 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 168 | 141 | 6 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 169 | 141 | 6 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 169 | 141 | 6 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 170 | 141 | 6 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.95e-05 | 174 | 141 | 6 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 2.29e-05 | 179 | 141 | 6 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 2.29e-05 | 179 | 141 | 6 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-05 | 180 | 141 | 6 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-05 | 180 | 141 | 6 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.44e-05 | 181 | 141 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-05 | 181 | 141 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 182 | 141 | 6 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 182 | 141 | 6 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 182 | 141 | 6 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-05 | 182 | 141 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 182 | 141 | 6 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 182 | 141 | 6 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 183 | 141 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 183 | 141 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 184 | 141 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-05 | 185 | 141 | 6 | 97f8a644f51c02a5f8a74d8c923ad637a15ed06d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.84e-05 | 186 | 141 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-05 | 186 | 141 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 187 | 141 | 6 | 08f2ecce3c08f35d995187b21bb7407a99dee4c2 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 187 | 141 | 6 | 939a068ac0913b9eeb5da4a9cb267d51cb711999 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 187 | 141 | 6 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 187 | 141 | 6 | e02e7f608506b9a48384f07727944f1cb8f7c575 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 188 | 141 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 188 | 141 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 3.02e-05 | 188 | 141 | 6 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 188 | 141 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 188 | 141 | 6 | 315ce1736e3a84a63a8d5dfa70d411b501cb2532 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-05 | 188 | 141 | 6 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-05 | 188 | 141 | 6 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.11e-05 | 189 | 141 | 6 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-05 | 189 | 141 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-05 | 189 | 141 | 6 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-05 | 190 | 141 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.30e-05 | 191 | 141 | 6 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.30e-05 | 191 | 141 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.39e-05 | 192 | 141 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 193 | 141 | 6 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 3.49e-05 | 193 | 141 | 6 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-05 | 193 | 141 | 6 | ad2df9b77999780860141be6ec366afc0172a331 | |
| Drug | UDP-FGlc | 2.16e-06 | 62 | 139 | 6 | CID000125643 | |
| Drug | beta-hydroxyasparagine | 3.84e-06 | 39 | 139 | 5 | CID000152191 | |
| Drug | AC1L9K72 | 1.21e-05 | 290 | 139 | 10 | CID000446872 | |
| Drug | 1-oleoyl-2-acetoyl-sn-glycerol | 1.22e-05 | 8 | 139 | 3 | ctd:C520323 | |
| Drug | fraxidin | 1.22e-05 | 8 | 139 | 3 | CID003083616 | |
| Drug | prostaglandin F2 | 1.92e-05 | 306 | 139 | 10 | CID000000160 | |
| Drug | vanadyl | 1.97e-05 | 307 | 139 | 10 | CID000061671 | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.52e-05 | 193 | 139 | 8 | 4146_DN | |
| Drug | Glyceraldehyde | 2.59e-05 | 10 | 139 | 3 | ctd:D005985 | |
| Drug | furegrelate | 2.81e-05 | 29 | 139 | 4 | CID000003436 | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 4370_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 3303_UP | |
| Drug | spermine | AMD1 IARS1 SPTAN1 GRIN2C REV3L PIK3CD KCNJ1 PLCB1 B4GALNT2 PLCG1 NOS2 | 3.13e-05 | 394 | 139 | 11 | CID000001103 |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 6278_UP | |
| Drug | isopetasin | 3.54e-05 | 11 | 139 | 3 | CID005318627 | |
| Disease | pulmonary hypertension (is_marker_for) | 5.87e-07 | 64 | 139 | 6 | DOID:6432 (is_marker_for) | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.17e-05 | 30 | 139 | 4 | DOID:6432 (is_implicated_in) | |
| Disease | Myoclonic Astatic Epilepsy | 1.64e-05 | 11 | 139 | 3 | C0393702 | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.18e-05 | 12 | 139 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | X-linked spondyloepiphyseal dysplasia tarda (implicated_via_orthology) | 2.20e-05 | 2 | 139 | 2 | DOID:0080362 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.20e-05 | 2 | 139 | 2 | C4551549 | |
| Disease | factor V deficiency (is_implicated_in) | 2.20e-05 | 2 | 139 | 2 | DOID:2216 (is_implicated_in) | |
| Disease | thrombophilia due to activated protein C resistance (is_implicated_in) | 2.20e-05 | 2 | 139 | 2 | DOID:0111902 (is_implicated_in) | |
| Disease | triglyceride change measurement, intermediate density lipoprotein measurement | 1.31e-04 | 4 | 139 | 2 | EFO_0007681, EFO_0008595 | |
| Disease | hepatitis (biomarker_via_orthology) | 1.31e-04 | 4 | 139 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | Lennox-Gastaut syndrome | 3.26e-04 | 6 | 139 | 2 | C0238111 | |
| Disease | Endotoxic shock | 3.26e-04 | 6 | 139 | 2 | C0036981 | |
| Disease | Septic Shock | 3.26e-04 | 6 | 139 | 2 | C0036983 | |
| Disease | Toxic Shock Syndrome | 3.26e-04 | 6 | 139 | 2 | C0600327 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 3.26e-04 | 6 | 139 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 4.56e-04 | 7 | 139 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Early Childhood Epilepsy, Myoclonic | 6.06e-04 | 8 | 139 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 6.06e-04 | 8 | 139 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 6.06e-04 | 8 | 139 | 2 | C0338479 | |
| Disease | Endotoxemia | 6.06e-04 | 8 | 139 | 2 | C0376618 | |
| Disease | Thrombophilia due to thrombin defect | 6.06e-04 | 8 | 139 | 2 | cv:C3160733 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 6.06e-04 | 8 | 139 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 6.06e-04 | 8 | 139 | 2 | C0438414 | |
| Disease | Venous Thromboembolism | 6.06e-04 | 8 | 139 | 2 | C1861172 | |
| Disease | Myoclonic Absence Epilepsy | 6.06e-04 | 8 | 139 | 2 | C0393703 | |
| Disease | hepatocyte growth factor-like protein measurement | 7.65e-04 | 38 | 139 | 3 | EFO_0008154 | |
| Disease | symmetrical dimethylarginine measurement | 7.76e-04 | 9 | 139 | 2 | EFO_0006523 | |
| Disease | Myoclonic Epilepsy | 7.76e-04 | 9 | 139 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.76e-04 | 9 | 139 | 2 | C3502809 | |
| Disease | Colonic Neoplasms | 7.84e-04 | 152 | 139 | 5 | C0009375 | |
| Disease | Malignant tumor of colon | 9.60e-04 | 159 | 139 | 5 | C0007102 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.67e-04 | 10 | 139 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Epilepsy, Myoclonic, Infantile | 9.67e-04 | 10 | 139 | 2 | C0917800 | |
| Disease | epilepsy (implicated_via_orthology) | 1.07e-03 | 163 | 139 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | glioblastoma (is_marker_for) | 1.18e-03 | 44 | 139 | 3 | DOID:3068 (is_marker_for) | |
| Disease | blood urea nitrogen measurement | 1.40e-03 | 452 | 139 | 8 | EFO_0004741 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.41e-03 | 12 | 139 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Essential Hypertension | 1.41e-03 | 12 | 139 | 2 | C0085580 | |
| Disease | Thromboembolism | 1.41e-03 | 12 | 139 | 2 | C0040038 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.66e-03 | 13 | 139 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | pleurisy (implicated_via_orthology) | 1.66e-03 | 13 | 139 | 2 | DOID:10247 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.66e-03 | 13 | 139 | 2 | C0751122 | |
| Disease | Colorectal Carcinoma | CHD1 SLC44A4 F5 ABCA9 BMPR1A ZNF540 AKR1B10 B4GALNT2 SPAG17 DNAH8 | 1.86e-03 | 702 | 139 | 10 | C0009402 |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 1.93e-03 | 14 | 139 | 2 | cv:C2931907 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.06e-03 | 189 | 139 | 5 | EFO_0009932 | |
| Disease | Hypertensive disease | 2.11e-03 | 190 | 139 | 5 | C0020538 | |
| Disease | thrombosis (is_implicated_in) | 2.22e-03 | 15 | 139 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | Blood Coagulation Disorders | 2.53e-03 | 16 | 139 | 2 | C0005779 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.53e-03 | 16 | 139 | 2 | C3203102 | |
| Disease | Atherosclerosis | 2.74e-03 | 59 | 139 | 3 | C0004153 | |
| Disease | Atherogenesis | 2.74e-03 | 59 | 139 | 3 | C1563937 | |
| Disease | Eye Abnormalities | 2.86e-03 | 17 | 139 | 2 | C0015393 | |
| Disease | asthma (is_marker_for) | 3.03e-03 | 126 | 139 | 4 | DOID:2841 (is_marker_for) | |
| Disease | chronotype measurement | DOCK3 PDE1C RGSL1 NMUR2 SLC44A4 RGS16 DNAH1 USP31 PPM1L EIF4G3 PROC | 3.12e-03 | 882 | 139 | 11 | EFO_0008328 |
| Disease | risk-taking behaviour | DDX19A TRPC6 CNRIP1 REV3L ADGRL4 ORC5 EIF4G3 TBC1D21 CNTN2 PROC | 3.41e-03 | 764 | 139 | 10 | EFO_0008579 |
| Disease | Calcium channel blocker use measurement | 3.44e-03 | 213 | 139 | 5 | EFO_0009930 | |
| Disease | dehydroepiandrosterone sulphate measurement | 4.10e-03 | 68 | 139 | 3 | EFO_0007001 | |
| Disease | coronary artery disease | PDE1A PDE1C SWAP70 CHD2 ACAD10 ACVRL1 LDLR BMPR1B THADA SHOC1 B4GALNT2 PLCG1 DENND5A | 4.29e-03 | 1194 | 139 | 13 | EFO_0001645 |
| Disease | Deep Vein Thrombosis | 4.36e-03 | 21 | 139 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 4.36e-03 | 21 | 139 | 2 | C0042487 | |
| Disease | eosinophil count | DOCK3 RAPGEF6 CHD1 ACAD10 DYSF TTC6 ADGRL4 THADA LMAN1 PIK3CD XRN1 PLD1 PLEC EIF4G3 NOS2 | 4.48e-03 | 1488 | 139 | 15 | EFO_0004842 |
| Disease | bipolar I disorder | 4.52e-03 | 141 | 139 | 4 | EFO_0009963 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVQRDTFVVWDKLSV | 201 | Q9HBW9 | |
| LQFAAWVDAVVFVFS | 151 | Q96P47 | |
| VLEFASKENFWDGIT | 321 | Q5W0A0 | |
| VTTKYVLWVDDDFLF | 391 | Q8NHY0 | |
| IFFSKFQWKIQAELD | 256 | Q6UX41 | |
| SEFWEKGFVAFQAAI | 171 | Q8IUA7 | |
| TEFVSNLAWDFAVKE | 586 | Q6JQN1 | |
| EDLFIVSKLWPTFFE | 71 | O60218 | |
| VAVKIFSSRDEQSWF | 226 | P37023 | |
| FRTFLFWNEGEKSSV | 306 | Q8TF62 | |
| VTAFEAKRTINAIWF | 61 | P21730 | |
| KVFFTTEEASWFRET | 231 | O00238 | |
| ENVHWFVLADFVKLS | 226 | P23280 | |
| KNLWIFVSKFTEFDA | 1476 | O14646 | |
| KISYADFVWFLISEE | 371 | Q9Y5P8 | |
| SFLKSEFSEENIEFW | 101 | Q08116 | |
| FLSEEEYWKLQIFFT | 31 | P24863 | |
| EDAFRSWAVQTFKAA | 666 | P35228 | |
| WATAYFDVLLDKFQV | 406 | Q08AI8 | |
| VNSFSWNLKELFFSD | 736 | Q96RG2 | |
| HFSWVFLDDVFEVKL | 876 | Q14667 | |
| ITNNLFQFEFKDKTW | 251 | Q8N653 | |
| FSFVEEWSESLAAVF | 291 | Q9GZQ4 | |
| VVFDLFFAQWVSDEN | 121 | P98073 | |
| WVAFDKQVLSFDAYL | 71 | Q5JST6 | |
| IVTLKDVDKWSFDVF | 151 | P54750 | |
| VDKWSFDVFSLNEAS | 166 | Q14123 | |
| VSFEDRVAKIIEWFT | 161 | Q9UJA9 | |
| IFQASFDDLWRKFVT | 1236 | Q96JB1 | |
| LIWFSDKTFEDSDLF | 781 | Q5GLZ8 | |
| FKIWAFLDVSFVERI | 371 | Q8N4B4 | |
| KTKAAFENWEVEVTF | 96 | P49257 | |
| FWEDDLAKETYIQFE | 616 | Q3SXY7 | |
| VSIDGVEWSDIKFFQ | 926 | Q6VY07 | |
| EIFQNVDDTLAFWSK | 71 | P04070 | |
| FWEQKEDFTFVSLLT | 491 | Q9P2D7 | |
| SFTWDVNEEAKIFIT | 356 | Q6ISB3 | |
| FTWDINDEAKVFISV | 361 | Q9NZI5 | |
| KNFTETDFDFKVWNS | 1021 | Q8IZD9 | |
| ILQWDFTEDFFNLTL | 181 | Q9C0J1 | |
| FNNSIVQDFFAWSKD | 316 | Q9P109 | |
| WFNEAIDFIDSIKNA | 236 | P28562 | |
| RNLWIFVSKFTEFDA | 1531 | O14647 | |
| FTDIGTFETVWQVKF | 111 | Q96F85 | |
| FFEGTEKLLEVWFSR | 6 | P17707 | |
| LLFSATFEDSVWKFA | 271 | Q9UMR2 | |
| KVFFTTEEASWFRET | 261 | P36894 | |
| IWDFIEKVVAYFETT | 1151 | Q6ZUT9 | |
| NFSISDWSKNFEVVF | 481 | O15033 | |
| TFTWTLDDFPIDFDK | 541 | Q02246 | |
| FKNVFIWDFLEKAQT | 1161 | Q6IQ26 | |
| NLIFDSEWVKREFVA | 346 | Q5I0G3 | |
| WEATSIYLVFAFEKQ | 461 | O43148 | |
| AFEVFDIETRSWTKF | 191 | Q8IYD2 | |
| DISVKIFEDFAQSWY | 216 | Q53GD3 | |
| KDAILEADTEFWFSV | 1436 | Q9H583 | |
| LFSATFEDSVWKFAQ | 271 | Q9NUU7 | |
| WSFDDIIVFAFSCKQ | 261 | Q8NBJ5 | |
| FSFEAWNAKITDLKQ | 721 | P78347 | |
| LWFGLSVDEKEFNQF | 856 | O75923 | |
| VVFQIWDNDKFSFDD | 1906 | O75923 | |
| KSVTAFFTWLREAEE | 1566 | O43432 | |
| VINEWDNKTFTFGSF | 1551 | Q8TE73 | |
| TWFDKALVSLVEEEF | 2841 | Q8TE73 | |
| AFFLVNDWLSVETEA | 3211 | P98161 | |
| KLAFSDTRVNEWVIF | 186 | P30953 | |
| FTVAEKEEWYTAFVN | 31 | Q9ULK6 | |
| KAISIWESKNFFFEL | 91 | Q9NPB1 | |
| SEFNNFEDWVKTFEL | 1286 | Q2WGJ9 | |
| FLDEEDYWFLLFTTQ | 486 | A5PLK6 | |
| DYLFEKAEVNFWAET | 1826 | Q6YHU6 | |
| KRFEDIVNQETFWVA | 901 | Q8TEU7 | |
| FVWDVKAIQAFNEFI | 896 | O60522 | |
| ETFWLFQFFLQKTEH | 181 | Q8IYX1 | |
| FWVRLTNEESHEVFF | 36 | P0DP42 | |
| IVLLFAVFDESKSWS | 211 | P12259 | |
| AVFAVFDENKSWYLE | 546 | P12259 | |
| SWNDFADFEKIFVKI | 201 | P09917 | |
| DESWTKFVKFQDIEV | 306 | Q8N0V4 | |
| KFFKEVWVSTAARNA | 981 | Q13393 | |
| TDVFWKSLDFKEQVA | 546 | P35251 | |
| FLKSEFSEENLEFWI | 81 | O15539 | |
| NVTVLFLSEIVWEKF | 151 | O43913 | |
| LWETIVFFSLAASKE | 11 | P23415 | |
| DVLEAEFSKTWEFKN | 76 | Q5SGD2 | |
| WEKFDPDATQFIEFS | 1786 | Q15858 | |
| ITFDITADLENIFDW | 66 | P61009 | |
| VLDQWKASFFVEDFL | 6 | Q5VXU9 | |
| VGTFADRWKFFEETS | 791 | Q13796 | |
| FVAVLFKSVDFNWLQ | 261 | Q9UNP4 | |
| FPAEEEKILEFWTEF | 11 | P41252 | |
| EKILEFWTEFNCFQE | 16 | P41252 | |
| VFTKDKEDFFNSQWD | 176 | Q8WTW4 | |
| AQKAVEFEGWADTLF | 241 | Q9NTN3 | |
| FNEDFKIFLTAQAWE | 136 | Q9UNH6 | |
| IFWEEVSDKFAFGLF | 336 | Q9UL12 | |
| SWNEVERAFKVFTFE | 591 | Q6Q759 | |
| NGTLINETVFEFDWK | 301 | P35498 | |
| EDLFIVSKVWPTFFE | 71 | C9JRZ8 | |
| DILLWAFDDTFFNLT | 191 | Q6UX72 | |
| FFLSATKLEEFIQWL | 261 | Q8NEL0 | |
| SDILINFKFHDFETW | 156 | Q96S66 | |
| SSKWVFFDDANVKEI | 311 | Q70EK8 | |
| KFDWTFEQTVETAIT | 186 | P60900 | |
| EDDVFLLDVWDQVFF | 646 | P09327 | |
| FKDVAVNFTQEEWAL | 6 | Q8IYI8 | |
| VTFRDVAIDFSQKEW | 6 | Q8NDQ6 | |
| AATVLEYFIKFWTNE | 186 | Q5W0Z9 | |
| FRDVAIEFSLAEWKF | 26 | Q96N58 | |
| VTFEDVAVYFIRKEW | 51 | P17036 | |
| FEEAVNFFTWALKIN | 226 | Q86TZ1 | |
| FAFLNEEKFNVDGWT | 151 | Q13496 | |
| FTFRVLSDWFDNKTD | 2496 | O60673 | |
| FQFFQRDAEELEKWI | 46 | Q13813 | |
| SAFLQFNWKADVVES | 1976 | Q13813 | |
| FTDVAIKFSLEEWQF | 6 | P0DPD5 | |
| FSEVFVDLKWFESKV | 351 | Q8IZH2 | |
| FRDVAIEFSLAEWKF | 26 | Q8N4W9 | |
| FWTKEENQSVVVDFL | 11 | O00329 | |
| DEFVTFLFSKENSVW | 296 | P19174 | |
| AFLKTEFSEENLEFW | 81 | O15492 | |
| SSFEEIEILWSQFLK | 446 | Q15149 | |
| ATKLDTWVFDNVKDF | 171 | O95427 | |
| AFQEEVAKEWTNEVF | 121 | Q9NQ66 | |
| LKTVDKFNEWFVSAF | 61 | P0DI81 | |
| FDDVAVTFTKEEWGQ | 16 | O43296 | |
| FDIITQWCFEIKSFT | 1711 | Q6ZT12 | |
| VSFKDVTIEFTQEEW | 46 | Q9Y2H8 | |
| TEEDAFKIWVIFNFL | 111 | Q9UH65 | |
| LVVEWDKETRDFLFV | 556 | Q70CQ4 | |
| EAFTTVEESFKTLFW | 666 | Q9Y210 | |
| VEESFKTLFWAIFGL | 671 | Q9Y210 | |
| TFEDVAVLFTEAEWK | 36 | Q86UQ0 | |
| LKTVDKFNEWFVSAF | 61 | P0DI82 | |
| FVDSVVSDILFKIWD | 836 | Q9UPU7 | |
| FVSFFNKWDAENAIQ | 151 | P31483 | |
| EFLAEDSQEKFWNFV | 66 | Q9NYU2 | |
| TVEESFKTLFWSIFG | 601 | Q13507 | |
| ESDFFTKTWGLDFVD | 86 | Q9P1Q0 | |
| VEESFKTLFWSIFGL | 616 | Q9HCX4 | |
| LTFKDISIDFTQEEW | 76 | Q49AA0 | |
| VTFADVAVNFTKEEW | 6 | Q8NC26 | |
| FKDVAVNFTQEEWAL | 21 | Q8NDP4 | |
| VEAQSRFIFFVDIWT | 56 | P48048 | |
| LAVFEDKVFWTDIIN | 611 | P01130 | |
| DKVFWTDIINEAIFS | 616 | P01130 | |
| VVQIVIFSESWAFAK | 26 | Q8NI32 | |
| ETFKIENNWYFVVAD | 336 | O95970 | |
| QVLFKVLEEYDWSAF | 151 | Q14957 |